{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:05:01Z","timestamp":1789617901268,"version":"build-2803163510"},"reference-count":131,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegenerative Disease Management"],"DOI":"10.1080\/17582024.2026.2734624","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:48:39Z","timestamp":1789616919000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Chronic psychostimulant exposure and vulnerability to Parkinson\u2019s disease: is there a role for brain iron?"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-7545","authenticated-orcid":false,"given":"Hugo A. E.","family":"Morandini","sequence":"first","affiliation":[{"name":"Child and Adolescent Health Service","place":["Nedlands, Australia"]},{"name":"The University of Western Australia","place":["Perth, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4652-1812","authenticated-orcid":false,"given":"Marcel","family":"Schulze","sequence":"additional","affiliation":[{"name":"University of Bonn","place":["Bonn, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-2427","authenticated-orcid":false,"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[{"name":"Florey Neuroscience Institute","place":["Melbourne, Australia"]},{"name":"University of Melbourne","place":["Melbourne, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0171-3881","authenticated-orcid":false,"given":"Lena","family":"Smirnova","sequence":"additional","affiliation":[{"name":"Johns Hopkins University","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-512X","authenticated-orcid":false,"given":"Tim J.","family":"Silk","sequence":"additional","affiliation":[{"name":"Deakin University","place":["Burwood, Australia"]},{"name":"Murdoch Children\u2019s Research Institute","place":["Parkville, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-7769","authenticated-orcid":false,"given":"Pradeep","family":"Rao","sequence":"additional","affiliation":[{"name":"Child and Adolescent Health Service","place":["Nedlands, Australia"]},{"name":"The University of Western Australia","place":["Perth, Australia"]},{"name":"The Kids Research Institute","place":["Perth, Australia"]},{"name":"University of Western Australia Medical School","place":["Perth, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2023.127190"},{"key":"e_1_3_3_4_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpsychires.2024.03.035","article-title":"Brain iron concentration in childhood ADHD: a systematic review of neuroimaging studies","volume":"173","author":"Morandini HA","year":"2024","unstructured":"Morandini HA, Watson PA, Barbaro P, et al. Brain iron concentration in childhood ADHD: a systematic review of neuroimaging studies. J Psychiatr Res. 2024;173:200\u2013209.","journal-title":"J Psychiatr Res"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-018-0632-3"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/920953"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2019.08.002"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00689-5"},{"issue":"4","key":"e_1_3_3_9_1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.27947","article-title":"Meta-analysis of copper and iron in parkinson\u2019s disease brain and biofluids","volume":"35","author":"Genoud S","year":"2020","unstructured":"Genoud S, Senior AM, Hare DJ, et al. Meta-analysis of copper and iron in parkinson\u2019s disease brain and biofluids. Mov Disord. 2020;35(4):662\u2013671.","journal-title":"Mov Disord"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep36669"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113094"},{"key":"e_1_3_3_12_1","doi-asserted-by":"crossref","first-page":"106539","DOI":"10.1016\/j.nbd.2024.106539","article-title":"MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson\u2019s disease: observational and genetic analysis in the UK biobank cohort","volume":"197","author":"Casanova F","year":"2024","unstructured":"Casanova F, Tian Q, Williamson DS, et al. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson\u2019s disease: observational and genetic analysis in the UK biobank cohort. Neurobiol Dis. 2024;197:106539.","journal-title":"Neurobiol Dis"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.6.999"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-024-02856-1"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20550"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209254"},{"issue":"2","key":"e_1_3_3_17_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease","volume":"21","author":"Devos D","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, et al. Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal. 2014;21(2):195\u2013210.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"e_1_3_3_18_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1877718X241300295","article-title":"Therapeutic modalities of deferiprone in Parkinson\u2019s disease: SKY and embark studies","volume":"15","author":"Devos D","year":"2025","unstructured":"Devos D, Rascol O, Meissner WG, et al. Therapeutic modalities of deferiprone in Parkinson\u2019s disease: SKY and embark studies. J Parkinsons Dis. 2025;15(1):72\u201386.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01402-2"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf398"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21374"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2021.23"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00392-2"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1492126"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000108984.11879.95"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00332-2"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1624376"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-018-0207-5"},{"key":"e_1_3_3_30_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.euroneuro.2020.06.001","article-title":"Evaluation of causality between ADHD and Parkinson\u2019s disease: mendelian randomization study","volume":"37","author":"Li G-Y","year":"2020","unstructured":"Li G-Y, Ge GM, Cheung C-L, et al. Evaluation of causality between ADHD and Parkinson\u2019s disease: mendelian randomization study. Eur Neuropsychopharmacol. 2020;37:49\u201363.","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-009-8059-y"},{"issue":"3","key":"e_1_3_3_32_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0925-4439(96)00020-8","article-title":"Dopamine, 6-hydroxydopamine, iron, and dioxygen\u2014their mutual interactions and possible implication in the development of Parkinson\u2019s disease","volume":"1316","author":"Linert W","year":"1996","unstructured":"Linert W, Herlinger E, Jameson RF, et al. Dopamine, 6-hydroxydopamine, iron, and dioxygen\u2014their mutual interactions and possible implication in the development of Parkinson\u2019s disease. Biochim Biophys Acta. 1996;1316(3):160\u2013168.","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033137"},{"issue":"2","key":"e_1_3_3_34_1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschemneuro.8b00454","article-title":"Impact of dopamine oxidation on dopaminergic neurodegeneration","volume":"10","author":"Zhang S","year":"2018","unstructured":"Zhang S, Wang R, Wang G. Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem Neurosci. 2018;10(2):945\u2013953.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"e_1_3_3_35_1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease?","volume":"8","author":"Herrera A","year":"2017","unstructured":"Herrera A, Mu\u00f1oz P, Steinbusch HW, et al. Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson\u2019s disease? ACS Chem Neurosci. 2017;8(4):702\u2013711.","journal-title":"ACS Chem Neurosci"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020296"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-013-9435-y"},{"key":"e_1_3_3_38_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnins.2019.00271","article-title":"On the role of aminochrome in mitochondrial dysfunction and endoplasmic reticulum stress in Parkinson\u2019s disease","volume":"13","author":"Segura-Aguilar J","year":"2019","unstructured":"Segura-Aguilar J. On the role of aminochrome in mitochondrial dysfunction and endoplasmic reticulum stress in Parkinson\u2019s disease. Front Neurosci. 2019;13:271.","journal-title":"Front Neurosci"},{"key":"e_1_3_3_39_1","doi-asserted-by":"crossref","first-page":"106528","DOI":"10.1016\/j.biocel.2024.106528","article-title":"To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson\u2019s disease","volume":"168","author":"Chagraoui A","year":"2024","unstructured":"Chagraoui A, Anouar Y, De Deurwaerdere P, et al. To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson\u2019s disease. Int J Biochem Cell Biol. 2024;168:106528.","journal-title":"Int J Biochem Cell Biol"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.7b00152"},{"key":"e_1_3_3_41_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnins.2018.00106","article-title":"Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson\u2019s disease","volume":"12","author":"Segura-Aguilar J","year":"2018","unstructured":"Segura-Aguilar J, Huenchuguala S. Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson\u2019s disease. Front Neurosci. 2018;12:106.","journal-title":"Front Neurosci"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.03.014"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.08.014"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfv016"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-018-9953-8"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-015-9560-x"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01173-5"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2182-5"},{"key":"e_1_3_3_49_1","doi-asserted-by":"crossref","first-page":"106083","DOI":"10.1016\/j.neuint.2025.106083","article-title":"Striatal injection of aminochrome in Wistar rats induces early-stage behavioral changes of Parkinson\u2019s disease and dopaminergic degeneration in the caudal and medial regions of the nigra pars compacta","volume":"191","author":"Teles-Souza J","year":"2025","unstructured":"Teles-Souza J, de Oliveira JVR, De Araujo FM, et al. Striatal injection of aminochrome in Wistar rats induces early-stage behavioral changes of Parkinson\u2019s disease and dopaminergic degeneration in the caudal and medial regions of the nigra pars compacta. Neurochem Int. 2025;191:106083.","journal-title":"Neurochem Int"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-012-9525-y"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.05.015"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.137"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.39"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/inorganics12040101"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.05.003"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.07.005"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.2174\/157015908787386041"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2005.03506.x"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4559-08.2009"},{"key":"e_1_3_3_60_1","first-page":"291","volume-title":"Handbook of neurotoxicity","author":"Mosharov EV","year":"2023","unstructured":"Mosharov EV. Dopamine homeostasis and role of VMAT2 in neurodegeneration. In: Kostrzewa RM, editor. Handbook of neurotoxicity. Cham: Springer International Publishing; 2023. p. 291\u2013311."},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02017.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.05.006"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-013-0798-1"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049483"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13357"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3602-07.2008"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.10.016"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-00134-x"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0319-07.2007"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.07.031"},{"issue":"25","key":"e_1_3_3_71_1","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity","volume":"29","author":"Taylor TN","year":"2009","unstructured":"Taylor TN, Caudle WM, Shepherd KR, et al. Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci. 2009;29(25):8103\u20138113.","journal-title":"J Neurosci"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2007.05108.x"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.11.006"},{"issue":"6","key":"e_1_3_3_74_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0924-977X(02)00104-9","article-title":"Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies","volume":"12","author":"Volkow ND","year":"2002","unstructured":"Volkow ND, Fowler JS, Wang G-J, et al. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur Neuropsychopharmacol. 2002;12(6):557\u2013566.","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.10.1325"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.11.1909"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.107.126888"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.07.002"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1680-4"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063023"},{"key":"e_1_3_3_81_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuint.2019.01.016","article-title":"Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum","volume":"124","author":"Quansah E","year":"2019","unstructured":"Quansah E, Zetterstr\u00f6m TS. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum. Neurochem Int. 2019;124:193\u2013199.","journal-title":"Neurochem Int"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11060940"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2023.107173"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2021.107017"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.04.007"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2019.08.003"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2013.35"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-009-0069-7"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111057"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-010-0229-9"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2019.06.010"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04059-0"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-010-0434-3"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14140047"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.21037\/qims-2024-2800"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101993"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-022-06484-7"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1822-8"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.013"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1139\/jpn.090044"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dcn.2023.101274"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2026.1735191"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13806"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-024-00768-1"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-025-02735-4"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00378-6"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1794-7"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92366-0"},{"issue":"47","key":"e_1_3_3_109_1","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","article-title":"Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease","volume":"105","author":"Salazar J","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2008;105(47):18578\u201318583.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"e_1_3_3_110_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2009.11.004","article-title":"Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson\u2019s disease","volume":"48","author":"Song N","year":"2010","unstructured":"Song N, Wang J, Jiang H, et al. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson\u2019s disease. Free Radic Biol Med. 2010;48(2):332\u2013341.","journal-title":"Free Radic Biol Med"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2013.03.025"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.08.569"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2018.11.006"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2023.02.005"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.271"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2023.09.006"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e3282f0d4f4"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27205"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056438"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.02.019"},{"issue":"14","key":"e_1_3_3_121_1","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson\u2019s disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan RC","year":"2010","unstructured":"Callaghan RC, Cunningham JK, Sajeev G, et al. Incidence of Parkinson\u2019s disease among hospital patients with methamphetamine-use disorders. Mov Disord. 2010;25(14):2333\u20132339.","journal-title":"Mov Disord"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22915"},{"key":"e_1_3_3_123_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","article-title":"Methamphetamine\/Amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment","volume":"146","author":"Curtin K","year":"2015","unstructured":"Curtin K, Fleckenstein AE, Robison RJ, et al. Methamphetamine\/Amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment. Drug Alcohol Depend. 2015;146:30\u201338.","journal-title":"Drug Alcohol Depend"},{"key":"e_1_3_3_124_1","doi-asserted-by":"crossref","first-page":"113793","DOI":"10.1016\/j.expneurol.2021.113793","article-title":"Methamphetamine and heightened risk for early-onset stroke and Parkinson\u2019s disease: a review","volume":"343","author":"Lappin JM","year":"2021","unstructured":"Lappin JM, Darke S. Methamphetamine and heightened risk for early-onset stroke and Parkinson\u2019s disease: a review. Exp Neurol. 2021;343:113793.","journal-title":"Exp Neurol"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-018-0126-2"},{"issue":"2","key":"e_1_3_3_126_1","first-page":"e60038","article-title":"Oxidative stress gated by Fenton and Haber Weiss reactions and its association with Alzheimer\u2019s disease","volume":"2","author":"Das TK","year":"2015","unstructured":"Das TK, Wati MR, Fatima-Shad K. Oxidative stress gated by Fenton and Haber Weiss reactions and its association with Alzheimer\u2019s disease. Arch Neurosci. 2015;2(2):e60038.","journal-title":"Arch Neurosci"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02088-5"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207748"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.09.071"},{"issue":"12","key":"e_1_3_3_130_1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention","volume":"15","author":"Ascherio A","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257\u20131272.","journal-title":"Lancet Neurol"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmac153"},{"key":"e_1_3_3_132_1","doi-asserted-by":"crossref","first-page":"119462","DOI":"10.1016\/j.jad.2025.119462","article-title":"ADHD and Parkinson\u2019s disease: unraveling the link and implications for early intervention","volume":"386","author":"Radomyslsky Z","year":"2025","unstructured":"Radomyslsky Z, Kivity S, Cohen R, et al. ADHD and Parkinson\u2019s disease: unraveling the link and implications for early intervention. J Affect Disord. 2025;386:119462.","journal-title":"J Affect Disord"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2024.08.015"}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17582024.2026.2734624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17582024.2026.2734624","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17582024.2026.2734624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:48:43Z","timestamp":1789616923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17582024.2026.2734624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":131,"alternative-id":["10.1080\/17582024.2026.2734624"],"URL":"https:\/\/doi.org\/10.1080\/17582024.2026.2734624","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}